smartbone: the innovative bone substitute for oral surgery and maxillofacial surgery
TRANSCRIPT
SmartBone is the next generation of osteogenic biomaterial for bone replacement in oral and maxillofacial surgery
Bone substitute
SmartBone is an innovative graft for bone replacement in oral and
maxillofacial reconstructive surgery
Hybrid bioactive material, partially synthetic and partially natural
- CE mark for all applications in bone regeneration- Class III Medical Device- Patented technology- Registered Trade Mark
BOVINE BONEMATRIX
BIODEGRADABLEPOLYMERS
CELLNUTRIENTS
OSTEOCONDUCTIVE
smartbone
ADVANTAGES• Dust free shaping• Resistance to extreme loads• High fixation tenacity• High volumetric stability• Strongly osteogenic
• Sinus Lift procedures• Vertical and horizontal
bone augmentations• Intrabony defects• Peri-implant defects
PERFECT FOR
MICROSTRUCTURE COMPARISON*ESEM
TARGET: Human Cortical Bone
CHEMICAL/PHYSICAL/BIOLOGICAL COMPATIBILITY
* Pertici G. et al., Tissue Engineering Part A, 2010
smartbone
HYBRID MICROSTRUCTURE COMPARISONESEM
(SAME MAGNIFICATION)
HEALTHY HUMAN BONE CADAVERIC BONE RTI STERLING
BOVINE BONEGEISTLICH BioOss
BOVINE BONEMORPHOLOGY Wide pores Too wide pores Too regular pores
FEATURES Too high variability Too high variability Low variability
MECHANICAL RESISTANCE Good strengths Fragile Extremely fragile
TOP SELLING US MARKET TOP SELLING COMPETITORPERFORMING COMPETITORTARGET
* Rossi F. et al., Journal of Tissue Engineering and Regenerative Medicine, 2014
SmartBone VOLUMERIC AND STRUCTURAL DATAVIA MICROCT SCAN*
EQUIVALENT VOLUME = 515 mm3
FREE VOLUME = 140 mm3 (27%)SURFACE = 23 cm2
* Pertici G. et al., Tissue Engineering Part A, 2010
SmartBone CHEMICAL CHARACTERIZATION*(E/SEM + EDS)
* Pertici G. et al., Annals of oral and maxillofacial surgery, 2014
IS A PERFECT COMPOSITE BIOMATERIALsmartbone
POLYMERIC COATING DEGRADATION*
Polymeric film thinning during time as degradationproceeds almost independently from starting thicknesses(2, 3, 5, 10 micron)
Complete polymer degradation after around 4 months:• Matches the natural bone ingrowth• Tissue regeneration
* Pertici G. et al., Annals of oral and maxillofacial surgery, 2014
BOVINE BONEMATRIX
BIODEGRADABLEPOLYMERS
CELLNUTRIENTS
smartbone
- 4 times better than the best-on-the-market (sterling)- 10 times better than the top-market-selling (biooss)
SmartBone MECHANICAL PERFORMANCESConstant speed, mono-axial, compression test performed on sterilized
samples
Rigid-elastic behaviour
* Pertici G. et al., European Cells and Materials, 2013
* Shu XZ et al., J Biomed Mater Res A, 2004; Kammerer PW et al., European Cells and Materials, 2011; Hennessy KM et al., Biomaterials, 2008; Hwang DS et al., Biomaterials, 2007; Bouhadir KH et al., Biotechnol Prog, 2001; Rosellini E et al., J Biomed
Mater Res A, 2009.
Cell nutrients are immobilized biomolecules containing the RGD (Arg-Gly-Asp) sequence, which promotes cell adhesion* and hence sparkles the formation of new bone*
BIOLOGY
BOVINE BONEMATRIX
BIODEGRADABLEPOLYMERS
CELLNUTRIENTS
smartbone
IN VITRO TEST
Porosity is optimal for cell adhesion and proliferation (all others have too big pores to
host cells)
Cells growth for 25 days into SmartBone
ESEM FLUORESCENCE HISTOLOGY
GFP+ SAOS-2 osteoblast-like cells cultured into
SmartBone
GFP+ SAOS-2 cells cultured intoSmartBone
- Extremely biocompatible- Very cell attractive- Readily absorbs blood- High mechanical stability
IT SPARKLES THE FORMATION OF NEW BONE!
human histology, 4 months after grafting
BIOLOGY
- Cytotoxicity (cell culture method)- Sensitization (Guinea Pig Maximisation)- Intracutaneous reactivity (Albino Rabbits)- Systemic toxicity test (on mice)- Implantation (Albino Rabbits at 4 and 8 weeks)- Genotoxicity (bacterial reverse mutation assay and mammalian cell gene mutation assay in mouse lymphoma L5178Y cells)
FULLY COMPLIANT WITH ISO 10993:2010 REQUIREMENTSOPTIMAL RESULTS DURING IN VIVO INVESTIGATIONS AND CLINICAL TRIALS
EXTREME SAFETY
7 x 7 x 7 mm10 x 10 x 10 mm10 x 10 x 20 mm10 x 20 x 20 mm14 x 12 x 6 mm14 x 12 x 7 mm14 x 12 x 8 mm14 x 12 x 9 mm14 x 12 x 10 mm14 x 12 x 12 mm14 x 12 x 16 mm14 x 12 x 20 mm14 x 12 x 24 mm15 x 30 x 20 mm15 x 30 x 30 mm15 x 30 x 40 mm15 x 30 x 50 mm15 x 30 x 60 mm16 x 14 x 6 mm16 x 14 x 7 mm16 x 14 x 8 mm16 x 14 x 9 mm
35 x 22 x 5 mm35 x 22 x 8 mm35 x 25 x 10 mm35 x 25 x 12 mm40 x 25 x 12 mm40 x 25 x 14 mm
∅ 11 x h 20 mm ∅ 12 x h 20 mm ∅ 14 x h 20 mm ∅ 11 x h 10 mm ∅ 14 x h 14 mm
15 x 6 x 4 mm15 x 7 x 3.5 mm
BLOCK3 x 25 x 15 mm3 x 10 x 10 mm4 x 10 x 10 mm
WEDGE
PLATE
CYLINDER
35 x 4 x 3 mmROD
U SHAPE
∅ 8 x h 12 mm
15 x 7 x 6 mm
C SHAPE
L SHAPE
0.25 - 1 mm (0.5 cc, 1 cc, 2 cc, 5 cc)1-2 mm(2 cc, 4 cc)2-4 mm(5 cc)
MICROCHIPS & GRANULES
SmartBone on DemandTHE NEW FRONTIER OF CUSTOM MADE BONE GRAFTS:
THE FUTURE IS HERE, TODAY!
CUSTOM MADE BONE GRAFTS FOR ORAL AND MAXILLOFACIAL RECONSTRUTIVE SURGERY*
* Grecchi F. et al., European Cells and Materials, 2013
CUSTOM MADE BONE GRAFTS NOW ALSO FOR POST-ONCOLOGIC RECONSTRUTIVE SURGERY*
* Anesi A. et al., in press EACMFS, 2014
DO’SPrepare the receiving site well
• properly expand soft tissues• properly microdrill native bone
Ensure a tight contact to host Bone• appropriate graft shaping• firmly tight screws
Smooth edges and cornersAlways use collagene membranes
DONT’SDo not overfill (avoid extra material,
itdoes not shrink)Do not mix with other materialsAvoid use OF 2-4 mm chips in oralapplications
IBI SA is an innovative hi-tech Swiss biomedical company focused on research, development and production of
medical devices for tissue engineering and regenerative medicine.
A NEW GENERATION OF BIOMATERIALS
www.ibi-sa.com
IBI has strong competencies and core skills in processing materials for biomedical applications, used to develop
proprietary technologies to produce new and innovative medical devices.
IBI believes that regenerative medicine and tissue engineering represent the future for health and key topic in life sciences.
IBI pays extreme attention to safety and quality: IBI is ISO13485-2012 and ISO9001-2008 certified; IBI production is
GMP certified.
is reserch
is vision
is quality
IBI SA Via Cantonale, 67CH-6805 Mezzovico-ViraSwitzerland
Information, data, clinical details, images and all that is embodied in this presentation are not disclosed to any third parties without the prior written consent of Industrie Biomediche Insubri SA.All rights reserved, 2015.